Skip to main content

Table 2 According to the research groups, the anthropometric and metabolic features of the individuals

From: Genetic predisposition to nonalcoholic fatty liver disease: insights from ANGPTL8 gene variants in Iranian adults

Variable

Group

P Value

NAFLD

Control

Mean ± SD

Median(Q1-Q3)

Mean ± SD

Median(Q1-Q3)

Age

54.55 ± 7.82

53.00 (48.75–61.00)

55.56 ± 7.90

55.00 (49.00–62.00)

0.148

BMI

27.01 ± 4.24

26.98 (24.07–30.14)

26.39 ± 3.70

26.07 (23.76–28.78)

0.078

Systolic pressure (mmhg)

130.86 ± 19.16

128.00 (117.50–143.00)

127.31 ± 18.18

125.00 (115.00–137.00)

0.061

Diastolic pressure

(mmhg)

80.00 ± 12.67

78.00 (72.50–88.00)

77.16 ± 12.73

75.00 (69.50–85.00)

0.002

FBG

100.25 ± 12.82

100.5 (90.75–110.00)

90.80 ± 11.19

125.00 (115.00–137.00)

< 0.001

Serum Insulin

8.69 ± 5.06

8.60 (5.00–11.33)

5.24 ± 3.91

75.00 (69.50–85.00)

< 0.001

HOMA IR

3.10 ± 2.17

2.83 (1.48–4.14)

1.24 ± 0.94

1.00 (0.54–1.59)

< 0.001

TG

151.77 ± 54.35

150.00 (117.50–143.00)

128.25 ± 51.37

119.00 (90.50–167.00)

< 0.001

Total Cholesterol

192.29 ± 45.19

197.5 (162.00–227.00)

165.18 ± 44.71

166.00 (136.50–194.00)

< 0.001

LDL Cholesterol

119.60 ± 35.89

118.00 (96.00–143.50)

100.30 ± 34.41

101.00 (77.00–123.50)

< 0.001

HDL Cholesterol

42.62 ± 8.00

42.00 (38.00–46.00)

44.65 ± 8.94

44.00 (39.00–50.00)

< 0.001

ALT

25.85 ± 11.61

23.80 (17.68–31.73)

21.02 ± 8.19

20.08 (14.25–26.70)

< 0.001

AST

23.41 ± 0.49

22.80 (18.90–27.80)

20.02 ± 0.46

18.80 (15.30–24.80)

< 0.001

RC

35.22 ± 17.12

35 (23–47)

27.82 ± 16.63

23 (16–38)

< 0.001

LSM

7.40 ± 2.57

7.2 (5.6–9.02)

5.49 ± 2.06

5 (4-6.45)

< 0.001